Another thrilling milestone for Sean Brecker and team ŌURA, congrats!!
Today, we’re proud to announce that OURA has raised $200M in Series D funding led by Fidelity Management & Research Company and Dexcom, the global leader in glucose biosensing. With this investment, Oura’s valuation has surpassed $5.2 billion, a milestone that validates our mission and approach. Founded in Oulu, Finland, more than 11 years ago, Oura’s mission then was the same as it is today; in the simplest terms, it’s to help all people live healthier lives. In the last decade, we’ve expanded our product offering, invested deeply in science, research, and validation, expanded our retail footprint and partnership portfolio, and doubled down in specific health areas like women’s health, heart health, stress & resilience, metabolic health, and more. We'll use this investment to expand our product offerings, fuel further investment in product, science, and healthcare innovation, including AI, advance global expansion efforts, and explore additional acquisitions to accelerate growth. More from TechCrunch: https://lnkd.in/g2fdpRfQ